Optimisation of second line antihormonal treatment for castration resistant metastatic prostate cancer
Background: The prognosis of castration resistant metastatic prostate cancer has been improved by several recently introduced therapeutic options, among others the second line antihormonal agents. Still, several questions related to the optimal use of these new drugs have remained open. The followin...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MRE Press
2022-04-01
|
| Series: | Journal of Men's Health |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/JOMH/18/4/10.31083/j.jomh1804093 |